Caring for someone with this diagnosis? Eleplan keeps diagnoses, medications, documents and every specialist in one plan.
Start free with EleplanAutosomal dominant optic atrophy plus syndrome
ORPHA:1215Disease
Also called ADOA+ · DOA+ · Optic atrophy-deafness-polyneuropathy-myopathy syndrome · Optic atrophy-hearing loss-polyneuropathy-myopathy syndrome
What it is
A rare neuro-ophthalmological disease associating the typical optic atrophy with other extra-ocular manifestations such as sensorineural deafness, myopathy, chronic progressive external ophthalmoplegia, ataxia and peripheral neuropathy. More rarely, other manifestations have been associated with this condition, such as spastic paraplegia or multiple-sclerosis like illness.
Key facts
- Prevalence
- 1-9 / 1 000 000 (Europe)
- Age of onset
- Adolescent, Adult, Childhood
- Inheritance
- Autosomal dominant
- Classified as
- Disease
Prevalence figures describe populations, not individuals, and are often estimates from a single study. Where the figure is an incidence or a birth prevalence, it says so.
Signs and symptoms
Common30–79%
11- Abnormality of visual evoked potentials
- Abnormal retinal nerve fiber layer morphology
- Absent brainstem auditory responses
- Bilateral ptosis
- EMG: impaired neuromuscular transmission
- Fatigue
- Limb-girdle muscle weakness
- Mitochondrial myopathy
- Myopathy
- Progressive external ophthalmoplegia
- Sensorineural hearing impairment
These ranges are how often a sign appears across everyone diagnosed, not a prediction for one person — most people have some of these and not others. Orphanet also records findings that are specifically absent in this disease; those are in the data but not listed here.
Gene
ICD-10 codes
ICD-10 has no distinct code for most rare diseases, so many are filed under the nearest available one. A shared code identifies the group, not this disease — the ORPHAcode above is what identifies it.
Related health topics
Reached through the ICD-10 categories this disease is filed under, so these describe the broader group rather than this disease specifically.
Cross-references
Orphadata Science: Free access data from Orphanet. © INSERM 1999. Data version 2026-06-23. Available under CC BY 4.0. This is a reference, not medical advice.
Powered by Eleplan
A rare diagnosis is just the start. Eleplan keeps the whole care plan in one place.
Diagnoses, medications, documents, appointments, and the whole care team — organized and always in sync, so you are not retelling the same story to every new specialist. With Ellie, your AI care assistant, on top of it. Free to start.